Sign In
Buy HCWB
$1.09
-0.0100 (-0.91%)
At Close: Jun 18, 2026
HCW Biologics Reports Second Quarter Financial Results and Recent Business Highlights
07:10am, Friday, 13'th Aug 2021
MIRAMAR, Fla., Aug. 13, 2021 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company”) (NASDAQ: HCWB), an innovative, biopharmaceutical company focused on discovering and developing novel immunothera
HCW Biologics Inc. Announces Closing of $56.0 Million Initial Public Offering
04:05pm, Thursday, 22'nd Jul 2021
MIRAMAR, Fla., July 22, 2021 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (NASDAQ:HCWB) (the "Company"), an innovative preclinical stage biopharmaceutical company focused on discovering and developing novel
